Clinical Trial Update: The Erythropoietin NeuroProtective Effect: Assessment in CABG Surgery (TENPEAKS) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating erythropoietin as a neuroprotective strategy in patients undergoing CABG surgery to mitigate brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University of Calgary | Conditions: Cardiac Surgery, Brain Injury | Phase 2 | Status: COMPLETED